However, DNAm of DLBCL-like RS differed from that of de novo DLBCL in terms of increased cell cycle activity and IGF1, ERK/MAPK, PI3K/AKT, and PD-1 signaling pathways. This evidence concerns the gene AKT1 and diffuse large B-cell lymphoma.